万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.e-cmh.org/
3、投稿网址：http://mc04.manuscriptcentral.com/cmh
4、官网邮箱：kasl@kams.or.kr（编辑部）
5、官网电话：+82-2-703-0051（编辑部）
6、期刊刊期：季刊，逢季首月出版。
2022年1月17日星期一
投稿须知【官网信息】
Instructions for authors
General Information
Clinical and Molecular Hepatology publishes original basic and clinical research on liver diseases. Manuscripts should be submitted electronically (http://submit.e-cmh.org/). The journal is published in English on 1st in January, April, July, and October. Authors lacking ability with English syntax should seek the appropriate editorial assistance prior to submitting their manuscripts.
These guidelines are in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals,” published by the International Committee of Medical Journal Editors at http://www.icmje.org.
The Editorial Office,
Clinical and Molecular Hepatology
Room A1210, Mapo Trapalace, 53 Mapo-daero, Mapo-gu, 04158, Seoul, Korea
Tel.: 82-2-703-0051, Fax: 82-2-703-0071, E-mail: kasl@kams.or.kr
Types of Manuscripts
Contributions may be submitted as original articles, case reports, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepatology issues elsewhere. Review articles, editorials and special topics are invited by the editorial board. However, authors who are interested in contributing reviews can submit reviews and are subjected to peer review. Letters to the editor may be subjected to peer review and undergo editing for clarity and brevity.
Ethical Conduct of the Study and the Report
All investigations involving human participants must be conducted according to the ethical guidelines of the Declaration of Helsinki, and be approved by the institutional review board. For studies involving animal experimentation, author(s) must provide assurance that all the animals received humane care according to the criteria outlined in the NIH "Guide for the Care and Use of Laboratory Animals". The author must state that the use of animals (means all mammals and birds) in the manuscript was approved by the institutional Animal Ethical Committee (AEC) in accordance to the article 14th of Korean Animal Protection Law, or equivalent, in the paper. It must be clearly stated that animal use has complied to the article 13th of Korean Animal Protection Law (The principles of animal use) and the relevant institutional polices in the manuscript. Copies of the protocol approved by institutional AEC or equivalents, must be available for review by the editor if necessary.
The corresponding author must give written assurance that neither the submitted material nor portions thereof have been published previously or are under consideration for publication elsewhere. Any material that could constitute prior or concurrent publication of similar data by any one of the authors should be submitted with the manuscript. It is assumed that the corresponding author speaks for his or her co-authors and certifies that all the listed authors meaningfully participated in the study and that they have seen and approved the final manuscript.
Authors should acknowledge any commercial affiliation or consultancy that could be constructed as potential conflicts of interest under a heading “Conflict of Interest statement” prior to the references.
For the policies on the research and publication ethics not stated in this instructions, ‘Good Publication Practice Guidelines for Medical Journals ( https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=7&per_page= )’or ‘Guidelines on good publication ( http://www.publicationethics.org.uk/guidelines )’ can be applied.
Ensure correct use of the terms sex (when reporting biological factors) and gender (Identity, psychosocial or cultureral factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender.
If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases, (e.g., prostate cancer).
Authors should define how they determined race or ethnicity and justify their relevance.
Organization of the Manuscript
The manuscript should be written in A4 (21×30 cm) paper in double space texts by leaving 3 cm space in the right, left, top and bottom sides at 10 point fonts.
Original articles
Original articles describing clinical and basic studies in the field of hepatology. Manuscripts are expected to be well-organized and clearly written. They should not exceed 6,000 words, including the abstract, references, tables, and figure legends. No more than 8 figures and tables, with a maximum of 6 panels per figure. It is permitted for you to submit additional methodological details, non-essential figures or portions of your manuscript as supplementary material for online publication only. References cited in the main text may not be listed in the supplementary materials. The only references be listed in the supplement are those cited exclusively in the supplement. References should not exceed a maximum of 50.
Original article must arranged as follows: (1) title page (2) abstract (250 words or less with a list of 5 or less key words), (3) introduction, (4) materials and methods (or patients and methods), (5) results, (6) discussion, (7) acknowledgements, (8) conflict of interest statement (9) references, (10) tables, and (11) figure legends.
……
更多详情：
https://www.e-cmh.org/authors/authors.php
